These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1534662)

  • 41. The neurochemistry of anxiety: an update.
    Nutt DJ; Glue P; Lawson C
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):737-52. PubMed ID: 1963497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.
    Griebel G
    Pharmacol Ther; 1995 Mar; 65(3):319-95. PubMed ID: 7644567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel hypothesis for the cause of panic disorder via the neuroepithelial bodies in the lung.
    Fukuda K
    Med Hypotheses; 2005; 64(6):1192-7. PubMed ID: 15823715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Information processing in anxiety: a pilot study of the effect of manipulating 5-HT function.
    Andrews TM; Anderson IM
    J Psychopharmacol; 1998; 12(2):155-60. PubMed ID: 9694028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of serotonin in panic: evidence from tryptophan depletion studies.
    Pyle AC; Argyropoulos SV; Nutt DJ
    Acta Neuropsychiatr; 2004 Apr; 16(2):79-84. PubMed ID: 26984000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates.
    Rosenblum LA; Coplan JD; Friedman S; Bassoff T; Gorman JM; Andrews MW
    Biol Psychiatry; 1994 Feb; 35(4):221-7. PubMed ID: 8186327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anxiety as a developmental disorder.
    Leonardo ED; Hen R
    Neuropsychopharmacology; 2008 Jan; 33(1):134-40. PubMed ID: 17851538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological concepts of anxiety disorders.
    Westenberg HG
    Acta Neuropsychiatr; 1997 Jun; 9(2):77-80. PubMed ID: 26972132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain Mechanisms Underlying Panic Attack and Panic Disorder.
    Guan X; Cao P
    Neurosci Bull; 2024 Jun; 40(6):795-814. PubMed ID: 37477800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Valeriana officinalis root extract suppresses physical stress by electric shock and psychological stress by nociceptive stimulation-evoked responses by decreasing the ratio of monoamine neurotransmitters to their metabolites.
    Jung HY; Yoo DY; Kim W; Nam SM; Kim JW; Choi JH; Kwak YG; Yoon YS; Hwang IK
    BMC Complement Altern Med; 2014 Dec; 14():476. PubMed ID: 25495725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.
    Coplan JD; Gopinath S; Abdallah CG; Berry BR
    Front Behav Neurosci; 2014; 8():189. PubMed ID: 24904340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association Study between 5-HT1A Receptor Gene C(-1019)G Polymorphism and Panic Disorder in a Korean Population.
    Choi WS; Lee BH; Yang JC; Kim YK
    Psychiatry Investig; 2010 Jun; 7(2):141-6. PubMed ID: 20577624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of chemoreceptors in mediating dyspnea.
    Buchanan GF; Richerson GB
    Respir Physiol Neurobiol; 2009 May; 167(1):9-19. PubMed ID: 19118647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A risk-benefit assessment of pharmacological treatments for panic disorder.
    Bennett JA; Moioffer M; Stanton SP; Dwight M; Keck PE
    Drug Saf; 1998 Jun; 18(6):419-30. PubMed ID: 9638387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
    Faludi G; Tekes K; Tóthfalusi L
    J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin related functions in panic-anxiety: a critical overview.
    Coplan JD; Gorman JM; Klein DF
    Neuropsychopharmacology; 1992 May; 6(3):189-200. PubMed ID: 1534662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonin function in panic disorder: important, but why?
    Maron E; Shlik J
    Neuropsychopharmacology; 2006 Jan; 31(1):1-11. PubMed ID: 16132063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Panic disorder: the potential role of serotonin reuptake inhibitors.
    Sheehan DV; Zak JP; Miller JA; Fanous BS
    J Clin Psychiatry; 1988 Aug; 49 Suppl():30-6. PubMed ID: 3045109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatments for panic disorder.
    Klerman GL
    J Clin Psychiatry; 1992 Mar; 53 Suppl():14-9. PubMed ID: 1532177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.